Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes
暂无分享,去创建一个
A. Califano | M. Bansal | J. Chabot | H. Hibshoosh | A. Sepulveda | T. Su | A. Iuga | K. Olive | J. Genkinger | P. Laise | Jing He | Sam R. Holmstrom | Aqeel Ahmed | Jiapeng Zhang | P. Oberstein | Carlo Maurer
[1] A. Califano,et al. Transcriptional deconvolution reveals consistent functional subtypes of pancreatic cancer epithelium and stroma , 2018, bioRxiv.
[2] J. Iovanna,et al. Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts , 2017, Cell reports.
[3] Steven J. M. Jones,et al. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. , 2017, Cancer cell.
[4] Christine A Iacobuzio-Donahue,et al. Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular-fibrosis and tumor progression , 2016, Nature Medicine.
[5] R. Gibbs,et al. Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.
[6] A. Butte,et al. Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.
[7] Jen Jen Yeh,et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma , 2015, Nature Genetics.
[8] D. Tuveson,et al. Stromal biology and therapy in pancreatic cancer: a changing paradigm , 2015, Gut.
[9] Michael A. Choti,et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets , 2015, Nature Communications.
[10] N. Jafari,et al. Evaluation of commercially available RNA amplification kits for RNA sequencing using very low input amounts of total RNA. , 2015, Journal of biomolecular techniques : JBT.
[11] J. Kench,et al. Whole genomes redefine the mutational landscape of pancreatic cancer , 2015, Nature.
[12] Stephen A. Sastra,et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. , 2014, Cancer cell.
[13] Aviv Regev,et al. Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples , 2013, Nature Methods.
[14] R. Vonderheide,et al. Inflammatory networks and immune surveillance of pancreatic carcinoma. , 2013, Current opinion in immunology.
[15] K. Olive,et al. Pancreatic cancer: why is it so hard to treat? , 2013, Therapeutic advances in gastroenterology.
[16] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.
[17] V. Velculescu,et al. Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors , 2012, Clinical Cancer Research.
[18] Derek S. Chan,et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer , 2012, Gut.
[19] Carlos Cuevas,et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[20] P. Spellman,et al. Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy , 2011, Nature Medicine.
[21] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[22] R. Abrams,et al. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] F. Pontén,et al. The Human Protein Atlas—a tool for pathology , 2008, The Journal of pathology.
[24] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[25] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[26] M. M. das Neves. [Tumor of the pancreas]. , 1994, Arquivos de gastroenterologia.
[27] V. Frantz. Tumor of the pancreas , 1959 .